Patent · US Active

Mycoplasma hyopneumoniae vaccine

US10668139B2 · kind B2 · utility

0Cited by
58References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 16, 2019
Grant dateJun 2, 2020
Priority date
Expiry dateJan 16, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2770/10034
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides a protein-A or protein-G treated Mycoplasma hyopneumoniae (M.hyo) antigen that is compatible with antigens from other swine pathogens, wherein the M.hyo antigen is an M.hyo culture supernatant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.